Quick answerCondition: suspected active pulmonary tuberculosis. Actions: mask him and move him to an airborne isolation room, and send three sputum samples for AFB smear and NAAT (with culture). Monitor: serial sputum AFB smears and fever and cough pattern.
Why this is correctWeeks of symptoms, constitutional signs (weight loss, night sweats), hemoptysis, a known contact, and an upper-lobe cavity together point to infectious pulmonary TB, which spreads by airborne droplet nuclei. The client wears a surgical mask as source control while moving to an airborne infection isolation room, and staff use fit-tested N95 respirators. Sputum specimens 8 to 24 hours apart (one early morning) with NAAT confirm the diagnosis and guide release from isolation. Smear conversion and fading fever and cough are the trends clinicians use to judge response and infectiousness.
Easy analogy or mental pictureTB in a cavity is like smoke in a room: a surgical mask on the smoker keeps some in, but everyone else needs a real respirator and the door needs to close on a negative-pressure room.
Memory hookCough 3 weeks + cavity + contact = airborne room, N95, and three sputums.
NCLEX decision ruleBegin isolation when a transmissible infection is suspected, collect diagnostic specimens before starting treatment, and monitor the markers that decide infectiousness.
Why the other choices are wrongCommunity-acquired pneumonia is the admission label and shares fever, cough, and WBC elevation, but three weeks of cough, weight loss, night sweats, a TB contact, and a cavity do not fit, so blood cultures and procalcitonin track the wrong disease. Latent TB is excluded because he has symptoms and a cavity; a tuberculin skin test measures infection, not disease activity or response. Lung cancer shares weight loss and hemoptysis but not fever, night sweats, and an infectious contact at age 38. Surgical masks do not protect staff from droplet nuclei; fit-tested N95 respirators are needed. An IGRA cannot rule out active TB and must not delay isolation. Starting drugs before sputum collection can make smears and cultures harder to interpret.
References
1CDC — TB Infection Control in Health Care SettingsAirborne precautions and respirator use for suspected infectious TB
2CDC MMWR — Guidelines for Preventing the Transmission of M. tuberculosis in Health-Care Settings, 2005AIIR placement, source control masking, and serial sputum collection